Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 1 of 16
<< Start
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
End >>
22.12.2017
Aura Biosciences Completes $30 Million Series C Financing
Press Release
26.10.2017
Acutus Medical® Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
Press Release
28.09.2017
NeRRe Therapeutics appoints Andrew Kay as Chairman of the Board
Press Release
27.09.2017
KaNDy Therapeutics launched to advance a breakthrough treatment in Women's Health
Press Release
10.05.2017
Iterum Secures $65 Million in Series B Financing
Press Release
03.05.2017
Axonics Announces $14.5 Million First Close of Series C Financing
Press Release
16.03.2017
Moximed Closes Oversubscribed $50MM Financing Round
Press Release
27.02.2017
Arrakis Therapeutics Announces $38M Series A Financing To Target RNA with Small-Molecule Medicines And Names Michael Gilman Chairman and CEO
Press Release
05.01.2017
NeRRe Therapeutics raises £23 million in oversubscribed Series B financing round
Press Release
29.09.2016
Aura Biosciences Secures $8 Million in Additional Funding
Press Release
©2018 Advent Life Sciences